Clinical Trials Logo
  1. Home
  2. Chronic Obstructive Pulmonary Disease
  3. NCT01698151
  4. Details
NCT01698151 Clinical Trial

Prognosis and Treatment of COPD in Primary Care-use of Biomarkers

Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial

— PROTECCT-M  

Official title:
Prognosis and Treatment of COPD in Primary Care-use of Biomarkers

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT01698151
Other study ID # S-20110163
Secondary ID
Status Recruiting
Phase N/A
First received September 28, 2012
Last updated March 7, 2016
Start date October 2012
Est. completion date December 2018

Study information
Verified date March 2016
Source University of Southern Denmark
Contact Frans Boch Waldorff, MD, PhD
Phone +45 6550 7643
Email fwaldorff@health.sdu.dk
Is FDA regulated No
Health authority Denmark: The Regional Committee on Biomedical Research Ethics
Study type Observational

Clinical Trial Summary

This is an observational study in primary care aiming to validate biomarkers for chronic obstructive pulmonary disease (COPD).

Recruitment information / eligibility
Status Recruiting
Enrollment 2000
Est. completion date December 2018
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender Both
Age group 40 Years to 100 Years
Eligibility Inclusion Criteria:

- 40 years old or more,

- diagnosis of COPD in primary care

Exclusion Criteria:

- Major psychiatric illness,

- inability to visit primary care doctor,

- inability to understand danish language,

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
Denmark Aaruplægerne Aarup
Denmark Lægerne i Bullerup Agedrup
Denmark Lægerne i Nr. Lyndelse Årslev
Denmark Lægehuset Skelvænget Assens
Denmark Lægerne Lægehuset Faaborg
Denmark Per Andersen Faaborg
Denmark Lægehuset i Gislev Gislev
Denmark Haarbylægerne Haarby
Denmark Jordløselægerne Haarby
Denmark Lægerne i Hesselager Hesselager
Denmark Lægerne i Hesselager Hesselager
Denmark Lægerne Glenthøj & Nielsen Kerteminde
Denmark Lægerne Tronegaard-Madsen og Schmidt Kerteminde
Denmark Muusgaarden Kerteminde
Denmark Lægerne i Kværndrup Kværndrup
Denmark Lægerne i Havnegade Middelfart
Denmark Nyhegn, Søndergaard, Trabjerg og Vilhelmsen Middelfart Fyn
Denmark Lægehuset i Morud Morud
Denmark Lægerne Nr. Voldgade Nyborg
Denmark Lægerne Nyenstad Nyborg
Denmark Bylægen Peer Kirkebjerg & Speciallæge Nanna Kirkebjerg Odense
Denmark Læge Bo Gamborg Nielsen Odense
Denmark Lægerne J.B. Winsløws Vej Odense Fyn
Denmark Peter Larsen Odense Fyn
Denmark Annette Tornøe Odense C
Denmark Kirsten Wengler Odense C
Denmark Læge Thore Eriksen Odense C
Denmark Lægerne Agertoft og Petersen Odense C
Denmark Peer Kirkebjerg Odense C Fyn
Denmark Almen Medicinsk Lægeklinik Odense SØ
Denmark Lægerne Banepladsen Otterup
Denmark Lægerne Lærkevej Otterup Fyn
Denmark Lægerne i Østergade Ringe
Denmark Lægehuset Rudkøbing I/S Rudkøbing
Denmark Lægerne Ørstedsgade Rudkøbing
Denmark Søndersø Lægehus Søndersø Fyn
Denmark Lægerne Toldbodvej Svendborg
Denmark Lægehuset i Vissenbjerg Vissenbjerg

Sponsors (3)
Lead Sponsor Collaborator
University of Southern Denmark Region of Southern Denmark, The Ministry of Science, Technology and Innovation, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome
Type Measure Description Time frame Safety issue
Primary Hospitalization December 1, 2015 No
See also
  Status Clinical Trial Phase
Completed NCT03282019 - Study of Long-term HFNC for COPD Patients With HOT N/A
Completed NCT05573464 - A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With the Hydrofluoroolefin Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease Phase 3
Recruiting NCT06040086 - Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations Phase 3
Not yet recruiting NCT06376994 - Multi-Center Clean Air Randomized Controlled Trial in COPD Phase 3
Completed NCT02926534 - Cross-Sectional Study of COPD Prevalence Among Smokers, Ex-smokers and Never-Smokers in Almaty, Kazakhstan N/A
Completed NCT02728674 - Management of Patients With Respiratory Symptoms in Sweden N/A
Completed NCT02797392 - Feasibility of a Preventive Program Against Lifestyle Related Diseases N/A
Recruiting NCT02415478 - Bronchioscopic Lung Volume Reduction (BLVR) N/A
Completed NCT02518139 - A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT03487406 - Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2) Phase 2
Completed NCT02459080 - Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT02512510 - Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT02774226 - Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease Phase 2
Withdrawn NCT01908933 - Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema Phase 3
Completed NCT01615484 - Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability N/A
Completed NCT01893476 - A Pragmatic Cluster Trial of a Tailored Intervention to Improve COPD Management N/A
Completed NCT01908140 - Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT01701869 - Microbiology & Immunology of the Chronically-inflamed Airway N/A
Recruiting NCT02527486 - Seoul National University Airway Registry N/A
Terminated NCT01388920 - Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting Phase 2

External Links